Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 06 Sep 2024

date Medical Devices & Consumables

new_biaoQian Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System

A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.

USD3480.00

Add To Cart

Add To Cart

Global Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System Supply, Demand and Key Producers, 2024-2030

date 06 Sep 2024

date Medical Devices & Consumables

new_biaoQian Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System

A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.

USD4480.00

Add To Cart

Add To Cart

A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.

USD3480.00

addToCart

Add To Cart

A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.

USD4480.00

addToCart

Add To Cart